Remed Co.,Ltd. (KOSDAQ:302550)
2,750.00
+35.00 (1.29%)
At close: Aug 24, 2026
Remed Revenue
Remed had revenue of 7.37B KRW in the quarter ending June 30, 2026, with 32.68% growth. This brings the company's revenue in the last twelve months to 27.05B, up 10.52% year-over-year. In the year 2025, Remed had annual revenue of 24.50B, down -4.11%.
Revenue (ttm)
27.05B
Revenue Growth
+10.52%
P/S Ratio
2.99
Revenue / Employee
310.95M
Employees
87
Market Cap
80.79B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 24.50B | -1.05B | -4.11% |
| Dec 31, 2024 | 25.55B | 7.02B | 37.86% |
| Dec 31, 2023 | 18.54B | -2.83B | -13.23% |
| Dec 31, 2022 | 21.36B | 1.17B | 5.79% |
| Dec 31, 2021 | 20.20B | 3.56B | 21.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Genoray | 108.27B |
| DRGEM | 106.74B |
| MEDIANA Co.,Ltd | 66.00B |
| JPI Healthcare | 47.97B |
| L&K Biomed | 39.53B |
| Hironic | 34.19B |
| SELVAS Healthcare | 30.19B |
| Dynamic solution | 15.46B |